|
Local drug manufacturer Beximco Pharmaceuticals Ltd (BPL) Tuesday introduced four new drugs for treatment of the Parkinson's disease, pain and inflammation, Psoriasis and Herpes viruses.
The drugs are Repitol for the Parkinson's disease, Dexifen for pain management, Ovalac for the treatment of Herpes viruses and Soritene ointment for Psoriasis, a skin disease.
The drugs have been launched for the first time by BPL in Bangladesh, Nazmul Hassan, chief executive officer of the company, said.
On the launching of Repitol, he said there is a significant number of patients in Bangladesh having Parkinsonism, and from now on the Beximco Pharma drug, Repitol, will be available in two strengths in the local market.
Another BPL drug Dexifen provides strong efficacy against pain and inflammation. Dexifen is available in three different strengths - 200 mg, 300 mg, and 400 mg tablets. The Soritene ointment works against Psoriasis. Soritene effectively treats psoriasis and can be used for long term due to its better safety profile.
On the other hand, Ovalac is an ideal second generation antiviral drug used to treat infections caused by herpes simplex and varicella-zoster virus.
|